tocacco plant Native American Tobaccoo flower, leaves, and buds

tocacco Tobacco is an annual or bi-annual growing 1-3 meters tall with large sticky leaves that contain nicotine. Native to the Americas, tobacco has a long history of use as a shamanic inebriant and stimulant. It is extremely popular and well-known for its addictive potential.

tocacco nicotina Nicotiana tabacum

tocacco Nicotiana rustica leaves. Nicotiana rustica leaves have a nicotine content as high as 9%, whereas Nicotiana tabacum (common tobacco) leaves contain about 1 to 3%

tocacco cigar A cigar is a tightly rolled bundle of dried and fermented tobacco which is ignited so that its smoke may be drawn into the mouth. Cigar tobacco is grown in significant quantities in Brazil, Cameroon, Cuba, Dominican Republic, Honduras, Indonesia, Mexico, Nicaragua, Sumatra, Philippines, and the Eastern United States.

tocacco Tobacco is an agricultural product processed from the fresh leaves of plants in the genus Nicotiana. It can be consumed, used as an organic pesticide, and in the form of nicotine tartrate it is used in some medicines. In consumption it may be in the form of smoking, snuffing, chewing, dipping tobacco, or snus.

tocacco

Star Scientific Reports on Filing Patent Application for Zero-Nitrosamine Tobacco Curing Process

Star Scientific and its wholly-owned subsidiary, Rock Creek Pharmaceuticals (”Rock Creek”), today reported on their continuing efforts to lessen the harm linked with tobacco use. Star Scientific, through its CEO Jonnie R. Williams, recently filed a new US Patent Application for a novel modification of its patented curing technology that results in the production of tobacco leaf that consistently contains levels of carcinogenic TSNAs (known as NNNs and NNKs) that are below detection even by the most sensitive measures. That patent application for zero-nitrosamine tobacco currently is pending before the US Patent and Trademark Office.

Rock Creek is exploring processes for the extraction of alkaloids from zero-nitrosamine tobacco for the purpose of using those alkaloids in the development of a generic nicotine replacement therapy (NRT), as well as a potential non-nicotine nutraceutical product. The nutraceutical would supply a dietary supplement for adult smokers who seek to minimize nicotine craving using a non-nicotine product. These development efforts are based in part on earlier research cited as support for the patents Star Scientific previously obtained for the use of tobacco alkaloids in treating various neurological conditions, including depression.

Curtis Wright, IV, MD, MPH, Medical Director of Rock Creek, stated, “We have acquired a large body of knowledge about why people smoke, and why smokers have been so unsuccessful in multiple quit attempts. We believe an appropriate strategy involves both an over-the-counter product and a parallel dietary supplement that may be of value in minimizing nicotine cravings.”

Rock Creek and Star Scientific recently have developed a prototype nutraceutical product. The prototype combines minor alkaloids of tobacco with other ingredients typical of botanical-based, dietary supplement products. Contracts for initial benchtop and animal toxicity testing have been entered into by Rock Creek. Additional toxicity testing is expected to begin in the next few months. If those testing results and consumer acceptance studies of this product are favorable, Rock Creek anticipates using the brand name CigRx(TM) when it begins its test marketing effort. During the intervening period Star Scientific will be exploring a joint venture with either a pharmaceutical company or a marketing and distribution partner in order to be in a position to achieve broad market penetration with the new nutraceutical product

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Star Scientific, Inc. and its consolidated subsidiaries (collectively, the “Company”) has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates”, “believes”, “estimates”, “expects”, “plans”, “intends” and similar expressions. These statements reflect the Company’s current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance or achievements to differ materially from those expressed in, or implied by, such statements. These risks, uncertainties and contingencies include, without limitation, the challenges inherent in new product development initiatives, the uncertainties inherent in the progress of scientific research, the Company’s ability to raise additional capital in the future necessary to maintain its business, potential disputes concerning the Company’s intellectual property, risks associated with litigation regarding such intellectual property, potential delays in obtaining any necessary government approvals of the Company’s low-TSNA tobacco products, market acceptance of the Company’s new smokeless tobacco products, competition from companies with greater resources than the Company, the Company’s decision not to join the Master Settlement Agreement (”MSA”), the effect of state statutes adopted under the MSA, and the Company’s dependence on key employees and on its strategic relationships with Brown & Williamson Tobacco Corporation in light of its combination with RJ Reynolds Tobacco Company, Inc. The impact of potential litigation, if initiated against or by individual states that have adopted the MSA, could be materially adverse to the Company.

Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that the expectations will be attained or that any deviation will not be material. See additional discussion under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008, as filed with the SEC on March 16, 2009, and other factors detailed from time to time in the Company’s other filings with the SEC, available at www.sec.gov. All information in this release is as of March 16, 2009, and the Company undertakes no obligation to update or advise upon any such forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Source: News.prnewswire

Related posts:

  1. Star Scientific Files First Quarter Financial Report Net sales for first quarter 2009, which totaled $.15 million,...
  2. Addressing the scientific challenges around combustible PREPs Setting the standard Standard scientific tests are essential to assess...
  3. Lorillard, Inc. Reports First Quarter 2009 Results Highlights Net sales were $917 million for the first quarter...
  4. Supreme Court Denies RJ Reynolds Petition Star Scientific, Inc.  announced that the United States Supreme Court...
  5. Imperial Tobacco reports six-month net loss British tobacco firm Imperial Tobacco Group Plc (IMT.L, ITYBF.PK, ITYBY.PK),...
  6. Curing of tobacco Curing and subsequent aging allows for the slow oxidation...
  7. Harm reduction The term ‘tobacco harm reduction’ does not have a single...
  8. Reynolds reports decline in first-quarter net income A substantial charge taken to reflect lower trademark values for...
  9. Massachusetts smokers can use a consumer protection law to sue Philip Morris The state’s highest court ruled Monday that Massachusetts smokers can...

2 comments to Star Scientific Reports on Filing Patent Application for Zero-Nitrosamine Tobacco Curing Process

  • Virgilk

    How will this new NRT be studied and by whom? Who can be trusted?

    I would like to point out the inescapable truth that
    there is no escape from pollution, because it is all
    around us. It makes no difference if we are inside
    our homes or outside in the wide open spaces of a park.
    Of all the substances that we are subjected to 24/7,
    Cigarette Smoke is by far the least harmful as pointed
    out in the links below. I have researched Smoking and
    SHS/ETS since 1998. I have found this push for smoking
    bans is about profit for the Pharmaceuticals who make
    smoking cessation products, not health. So, if you are
    worried about your right to breath clean air?
    It’s not in;
    your homes because of the materials it’s built from.
    your own Kitchen because of cleaning products.
    your yard because of the insecticides you spray.
    your car because of the materials used in the upholstery and the fumes that come into your car while driving.
    Nowhere outside because of the pollution due to gas/diesel engines.

    Ignore the fact that the EPA Report was vacated as fraudulent.
    Ignore over 250+ studies showing no harm from SHS.
    They don’t tell us that living close to major traffic hi-ways or large Urban areas increase the incidence of Cancer or Heart Disease by 50% or more.
    Ignore the businesses going broke across the Country because of Bans.
    We do have, agencies using misinformation to control others for profit not health.

    Smoking Studies.
    http://encyclopedia.smokersclub.com/163.html

  • Virgilk

    According to a 1999 study by the National Academy of Sciences, arsenic in drinking water causes bladder, lung and skin cancer, and may cause kidney and liver cancer. The study also found that arsenic harms the central and peripheral nervous systems, as well as heart and blood vessels, and causes serious skin problems. It also may cause birth defects and reproductive problems.
    http://www.nrdc.org/water/drinking/qarsenic.asp#health\
    If you noticed, all of the Arsenic problems are also attributed to Tobacco.
    The EPA refuses to mandate the removal of at least eleven Toxins/Carcinogens from our drinking water. Now we find, even Jay Leno knows, that Pharmaceuticals are dumping tons of Chemicals in our rivers.
    It is time to stop holding Smokers responsible since they are not the cause.

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word